高级检索
当前位置: 首页 > 详情页

Rationale and Design of a Cluster Randomized Trial of a Village Doctor-Led Intervention on Hypertension Control in China

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

单位: [1]China Med Univ, Dept Cardiol, Hosp 1, Shenyang, Liaoning, Peoples R China [2]Ctr Dis Control & Prevent Liaoning Prov, Dept Chron Dis, Shenyang, Liaoning, Peoples R China [3]Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Cardiovasc Med, Med Coll, Xian, Shanxi, Peoples R China [4]Huazhong Univ Sci & Technol, Tongji Hosp, Dept Internal Med, Div Cardiol,Tongji Med Coll, Wuhan, Hubei, Peoples R China [5]China Med Univ, Dept Clin Epidemiol, Shengjing Hosp, Shenyang, Liaoning, Peoples R China [6]Hanzhong Peoples Hosp, Cardiovasc Res Inst, Hanzhong, Shanxi, Peoples R China [7]Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70118 USA
出处:
ISSN:

关键词: blood pressure blood pressure control cardiovascular disease cluster randomized trials hypertension implementation strategies rural China village doctor

摘要:
BACKGROUND In China, hypertension prevalence is high and increasing while the control rate is low, especially in rural areas. Traditionally, village doctors play an important role in infectious disease control and delivering essential health services to rural residents. We aim to test the effectiveness of a village doctor-led multifaceted intervention compared with usual care on blood pressure (BP) control and cardiovascular disease (CVD) among rural residents with hypertension in China. METHODS In the China Rural Hypertension Control Project (CRHCP), a cluster randomized trial, 163 villages were randomly assigned to the village doctor-led intervention and 163 villages to control. A total of 33,995 individuals aged >= 40 years with an untreated BP >= 140/90 mm Hg or treated BP >= 130/80 mm Hg or with an untreated BP >= 130/80 mm Hg and a history of clinical CVD were recruited into the study. The village doctor-led multifaceted intervention is designed to overcome barriers at the healthcare system, provider, patient, and community levels. Village doctors receive training on standard BP measurement, protocol-based hypertension treatment, and health coaching. They also receive technical support and supervision from hypertension specialists/primary care physicians and performance-based financial incentives. Study participants receive health coaching on home BP monitoring, lifestyle changes, and adherence to medications. The primary outcome is BP control (<130/80 mm Hg) at 18 months in phase 1 and CVD events over 36 months in phase 2. CONCLUSIONS The CRHCP will provide critically important data on the effectiveness, implementation, and sustainability of a hypertension control strategy in rural China for reducing the BP-related CVD burden. CLINICAL TRIALS REGISTRATION Trial Number NCT03527719.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2020]版:
大类 | 3 区 医学
小类 | 3 区 外周血管病
最新[2025]版:
大类 | 3 区 医学
小类 | 3 区 外周血管病
JCR分区:
出版当年[2019]版:
Q3 PERIPHERAL VASCULAR DISEASE
最新[2023]版:
Q2 PERIPHERAL VASCULAR DISEASE

影响因子: 最新[2023版] 最新五年平均 出版当年[2019版] 出版当年五年平均 出版前一年[2018版] 出版后一年[2020版]

第一作者:
第一作者单位: [1]China Med Univ, Dept Cardiol, Hosp 1, Shenyang, Liaoning, Peoples R China
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:589 今日访问量:0 总访问量:441 更新日期:2025-06-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)